CorMedix agreed to acquire almost all of Heron's assets and will issue shares to Heron. The filing gives no asset or share values, so it does not show whether the deal helps or hurts CorMedix.
The assets could expand CorMedix's business. Issuing shares gives Heron part ownership and leaves existing shareholders with a smaller share of the company. The filing excerpt gives no asset list or share count, so it does not show whether the assets justify the shares.
Heron will transfer almost all its assets and receive CorMedix shares. With no asset or share values in this filing, it does not show whether the exchange helps or hurts Heron.
Follow CorMedix Inc. (CRMD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CRMD